Cargando…
Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study
OBJECTIVE: Patients with type II diabetes have an increased risk of bladder cancer and are commonly treated with thiazolidinediones and angiotensin receptor blockers (ARBs), which have been linked to cancer risk. We explored the relationship between use of one or both of these medication types and i...
Autores principales: | Mackenzie, Todd A., Zaha, Rebecca, Smith, Jeremy, Karagas, Margaret R., Morden, Nancy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801809/ https://www.ncbi.nlm.nih.gov/pubmed/26894755 http://dx.doi.org/10.1007/s13300-016-0152-4 |
Ejemplares similares
-
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A retrospective cohort study of older Medicare patients
por: Morden, Nancy E., et al.
Publicado: (2011) -
Response to Comment on: Morden et al. Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A Retrospective Cohort Study of Older Medicare Patients. Diabetes Care 2011;34:1965–1971
por: Morden, Nancy E., et al.
Publicado: (2012) -
Pharmacotherapy for Pediatric Neurogenic Bladder
por: Kroll, Paweł
Publicado: (2017) -
Current pharmacotherapy of overactive bladder
por: Kreydin, Evgenyi I., et al.
Publicado: (2021) -
Receipt of Medications for Chronic Disease During the First 2 Years of the COVID-19 Pandemic Among Enrollees in Fee-for-Service Medicare
por: Morden, Nancy E., et al.
Publicado: (2023)